Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches.
Authors:
Open Access
- 8 January 2021
- journal article
- review article
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 49 (1) , 118-127
Abstract
Chronic mucocutaneous candidiasis (CMC) is characterized by a chronic or recurrent non invasive infection, mainly due to Candida albicans , in skin, nails, and mucous membranes, associated in some cases with autoimmune manifestations. The key immune defect is disruption of the action of cytokine IL-17, whose most common genetic etiology is STAT1 gene gain-of function (GOF) mutations. The initial appropriate treatment for fungal infections is with azoles. However, frequent occurrence of drug resistance is the main limitation. Therefore, identification of the underlying inborn error if immunity in CMC may allow widening therapeutic options aimed at restoring immunological function. Type I and II Janus Kinase -inhibitors have been shown to control CMC in cases associated with STAT1 GOF. In this review, we delve into the pathogenesis of CMC and the underlying immune mechanisms. We describe the reported genetic defects in which CMC is the main manifestation. Diagnostic and therapeutic approaches for these patients are also offered.Keywords
This publication has 40 references indexed in Scilit:
- El nuevo escenario de las inmunodeficiencias primarias y el rol del inmunólogo clínico en la consulta especializadaAnales de Pediatría, 2020
- Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical ClassificationJournal of Clinical Immunology, 2020
- An Update on Syndromes with a Hyper-IgE PhenotypeImmunology and Allergy Clinics of North America, 2019
- Extended immunophenotyping reference values in a healthy pediatric populationCytometry Part B: Clinical Cytometry, 2018
- Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function MutationJournal of Clinical Immunology, 2018
- A 1-Year-Old Girl with a Gain-of-Function STAT1 Mutation Treated with Hematopoietic Stem Cell TransplantationJournal of Clinical Immunology, 2013
- An ACT1 Mutation Selectively Abolishes Interleukin-17 Responses in Humans with Chronic Mucocutaneous CandidiasisImmunity, 2013
- Th17 Cells in Immunity to Candida albicansCell Host & Microbe, 2012
- Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?Current Opinion in Immunology, 2010
- Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasisDiagnostic Microbiology and Infectious Disease, 2008